Why the study?
Does clopidogrel inhibit platelet-leukocyte adhesion and platelet-dependent leukocyte activation in mouse and human models?
Does clopidogrel inhibit platelet-leukocyte adhesion and platelet-dependent leukocyte activation in mouse and human models?
Clopidogrel reduces platelet-dependent up-regulation of inflammatory and pro-atherothrombotic functions in leukocytes, which may help reduce inflammation underlying atherosclerosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for clopidogrel's anti-inflammatory effects in atherosclerosis; human trials needed before clinical adoption.
Clopidogrel is considered to be an important therapeutic advance in anti-platelet therapy. We investigated whether inhibition by clopidogrel results in a reduced capacity of platelets to adhere and stimulate pro-atherothrombotic and inflammatory functions in polymorphonuclear leukocytes (PMN) and in monocytes (MN). An eventual effect on these processes could further substantiate anti-atherothrombotic properties of this drug. The effects of clopidogrel or of its active metabolite were investigated on ADP or thrombin receptor-induced platelet activation and on platelet-leukocyte interactions ex vivo in the mouse or in vitro in isolated human cells or whole blood, respectively. Clopidogrel inhibited platelet aggregation, expression of P-selectin, platelet-PMN adhesion and platelet-dependent ROS production in mouse PMN. Similarly pretreatment of human platelets with the active metabolite of clopidogrel in vitro resulted in a profound inhibition of platelet P-selectin expression, platelet-PMN adhesion and production of ROS by PMN. Pretreatment with the active metabolite of clopidogrel significantly impaired the ability of platelets to up-regulate the expression of TF procoagulant activity in MN, in a washed cell system. Moreover, the active metabolite of clopidogrel inhibited rapidTF exposure on platelet as well as on leukocyte surfaces in whole blood. By reducing platelet-dependent up-regulation of inflammatory and pro-atherothrombotic functions in leukocytes, clopidogrel may reduce inflammation that underlies the chronic process of atherosclerosis and its acute complications.
No takes yet. Share an insight, caveat, or question.
Manarini et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: